NORML

MARCH 1, 2019

The American Psychological Association (APA) is urging US Attorney General William Barr to review more than two-dozen pending applications for federal marijuana grow licenses. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. Also on Wednesday, Rep.

DEA 168

DEA Research and Development Clinical Trials Marijuana 168

Cannabis Law Report

NOVEMBER 4, 2021

It seems like every day I read a new story about legislators, high-ranking federal officials, and frustrated advocates of marijuana research complaining that researchers still can’t study the actual marijuana that people are using in the state-legal markets. Use the plants for their own studies and/or FDA clinical trials.

DEA 52

DEA Clinical Trials Advocacy Legislation 52

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. “DEA View original article.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

MARCH 30, 2022

The action represents one of the very few occasions that members of the Senate have ever advanced a marijuana-related reform bill. Under this proposal, the AG is also provided with the ability to authorize increases in the total number of federally approved marijuana cultivators. BILLS-117s253es. The full text of S.

Legislation 95

Legislation Clinical Trials DEA Access 95

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

Canna Law Blog

NOVEMBER 27, 2021

DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer.

Therapy 87

Therapy Clinical Trials DEA Microdosing 87

NORML

DECEMBER 9, 2020

The post House Passes Bipartisan Bill Facilitating Clinical Cannabis Research, Allowing Scientists to Access State-Approved Marijuana Products appeared first on NORML.

Access 246

Access Marijuana Clinical Trials Cannabis 246

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. We know such categorization is baseless and false.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

SpeedWeed

JULY 23, 2021

When you’re talking about wanting to do an actual clinical trial, you need a diversity of people that participate and one state just does not have the diversity of people that are required,” Towle said. Denver Company Moves Forward with Research License . Denver’s MedPharm Drives Research Further.

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. in each of the four validation trials with an acceptable yield, which is a noteworthy accomplishment.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

SpeedWeed

AUGUST 11, 2021

The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. With a goal of determining the “the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”. MAPS Makes History.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

SEPTEMBER 20, 2019

The sale will greatly reduce the current and future burn rate of the company and allow it to focus on achieving profitability, seeking a DEA license, and implementing GMP, a set of regulations promulgated by the U.S. location.

Clinical Trials 40

Clinical Trials Research and Development DEA Business 40

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Veriheal

APRIL 11, 2022

Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. Drug Enforcement Agency (DEA). The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

CannaMD

AUGUST 8, 2020

THC is responsible for marijuana’s psychoactive effects. CBD’s also known for its calming, pain-relieving effects – although, it’s important to point out that THC-rich products are more often recommended for severe pain (to learn more, see: Marijuana & Cancer Pain ). Hemp VS. Marijuana. One more difference?

CBD 100

CBD DEA Research and Development Hemp 100

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 351

Cultivation DEA Clinical Trials Marijuana 351

SpeedWeed

MARCH 25, 2021

A long-awaited clinical trial on using cannabis as a treatment for veterans with PTSD has finally been published in the PLOS One journal , but the results are far less promising than researchers and veterans had hoped. million grant from the Multidisciplinary Association of Psychedelic Studies (MAPS).

DEA 52

DEA Clinical Trials THC Pharmaceutical 52

SpeedWeed

MARCH 18, 2021

For years, many military veterans have used medical marijuana to manage the symptoms of PTSD. For Veterans With PTSD, Medical Marijuana Can Mean a Good Night’s Sleep. for the production of cannabis used in federally-regulated clinical trials. Wasn’t the DEA going to let others grow research-grade cannabis?

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Weedistry

MARCH 7, 2019

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find.

THC 40

THC CBD Clinical Trials Research and Development 40

Cannabis Law Report

MARCH 2, 2020

Any approved medicines will have to be rescheduled by the Drug Enforcement Administration (DEA). Back in 2018, the DEA rescheduled GW Pharmaceuticals ‘ (NASDAQ: GWPH) cannabis-based epilepsy medicine, Epidiolex, following its regulatory approval by the FDA. Fortunately, this issue shouldn’t be a show-stopper.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Veriheal

JUNE 24, 2021

health official reportedly slammed “ongoing federal restrictions that are inhibiting research into marijuana”. The Senator stated that the NIH has been reporting on “potentially promising peer-reviewed clinical research” and asked for an update on how the NIH was planning to proceed and navigate issues. .

Research and Development 52

Research and Development Clinical Trials Treatment Access 52

Cannabis Law Report

APRIL 1, 2019

It aims to turn the plants’ chemical compounds into 2,500 5-milliliter bottles – the size of a teaspoon – of cannabis oil and sublingual drops for clinical trials among volunteer patients as early as July. It remains to be seen whether the Drug Enforcement Authority, or DEA, will designate cannabis zones for these farmers.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Differing brands of marijuana could interact with the already current use of general anesthesia,” Vaibhav theorizes. .

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

JANUARY 11, 2019

It is now deemed an agricultural commodity, no longer able to be classified as a controlled substance, like marijuana. Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Canna Law Blog

NOVEMBER 6, 2021

The following year, President Richard Nixon declared drug abuse public enemy number one, and in 1973, he formed the Drug Enforcement Administration (DEA). Instead, qualifying evidence may come from adequate and well-controlled clinical trials. Phase I trials should be sufficient, and many have been completed using psilocybin.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

JUNE 4, 2021

Dr Stuart Titus the CEO at Medical Marijuana Inc. is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. His first-hand experience with therapeutic hemp oil products as nutritional supplements led him to Medical Marijuana Inc.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Veriheal

DECEMBER 21, 2022

President Joe Biden has officially signed a marijuana research bill into law. 8454, the “Medical Marijuana and Cannabidiol Research Expansion Act,” has been passed. attorney general 60 days to either approve a given application or request supplemental information from the marijuana research applicant. The law gives the U.S.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

Canna Law Blog

MAY 7, 2020

One of the main reasons why “marijuana” remains a federally illegal, Schedule I controlled substance is that, according to the Feds, it has no currently accepted medical use. Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

Cannabis Law Report

OCTOBER 20, 2021

Bank of America (BoA) is reportedly terminating its banking relationship with Scottsdale Research Institute (SRI), a DEA-registered facility that carries out important marijuana research. The quality of this cannabis had been criticised by a number of researchers, including Dr. Sisley.

Banking 52

Banking Clinical Trials DEA History 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Members of Congress voiced support for marijuana/AIDS research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

CannaMD

NOVEMBER 15, 2020

Funding of Marijuana Research. research on marijuana harms – such as cannabis withdrawal, treatments for substance abuse and use/exposure during pregnancy or infancy – received 20 times more funding than research on cannabis therapeutics. In Canada, recreational marijuana use was legalized in October 2018. stance on marijuana.

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

The Cannigma

MAY 6, 2021

This compound is produced in very small amounts in marijuana and hemp, but most of what is on the market today is converted synthetically in a lab and sold in amounts largely unseen in nature. . The only clinical trial on delta-8-THC involving humans was done on children in Israel in 1995. Delta-8-THC research.

THC 145

THC Cannabinoids Concentrates Hemp 145

Canna Law Blog

FEBRUARY 4, 2019

Canada legalized recreational marijuana for the entire country. took significant steps to decriminalize or legalize medical or recreational marijuana. In December, Israel became the fifth country to pass legislation legalizing the export of medical marijuana (after the Netherlands, Canada, Uruguay, and Australia).

Clinical Trials 80

Clinical Trials Recreational Medicine DEA 80

Cannabis Law Report

MARCH 21, 2019

I will not cover the legal status of marijuana or any other substance. Unlike marijuana which contains large quantities of the cannabinoid THC that is responsible for making you feel high, CBD will not make you high. Most states have different laws and regulations individually pertaining to CBD and marijuana. What is CBD?

State Laws 55

State Laws Law CBD Legalization 55